| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -22.49M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, SABS returned +71.3% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +0.5% |
| 1 year | +71.3% |
| 5 years | -96.2% |
| All-time high | $108.90 (Nov 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in SABS would be worth today ›No. SAB Biotherapeutics, Inc. has not paid a dividend in the past 12 months.
SAB Biotherapeutics, Inc. stock trades on NASDAQ under the ticker symbol SABS.
SAB Biotherapeutics, Inc. is part of the Healthcare sector.
SAB Biotherapeutics, Inc. has a market cap of 342.11M USD, based on the latest quote.
